摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[3,5-dibromo-4-(3-ethylaminobenzyloxy)phenyl]propionic acid

中文名称
——
中文别名
——
英文名称
3-[3,5-dibromo-4-(3-ethylaminobenzyloxy)phenyl]propionic acid
英文别名
3-(3,5-Dibromo-4-{[3-(ethylamino)phenyl]methoxy}phenyl)propanoic acid;3-[3,5-dibromo-4-[[3-(ethylamino)phenyl]methoxy]phenyl]propanoic acid
3-[3,5-dibromo-4-(3-ethylaminobenzyloxy)phenyl]propionic acid化学式
CAS
——
化学式
C18H19Br2NO3
mdl
——
分子量
457.162
InChiKey
HNHRKBWCJIABCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    24
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    58.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-硝基溴苄sodium hydroxide 、 sodium tetrahydroborate 、 sodium dithionite 、 potassium carbonate 作用下, 以 甲醇乙醇丙酮 为溶剂, 反应 21.67h, 生成 3-[3,5-dibromo-4-(3-ethylaminobenzyloxy)phenyl]propionic acid
    参考文献:
    名称:
    Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity
    摘要:
    Based on the concept of 'indirect antagonism' of nuclear receptors, a series of thyroid hormone receptor (TR) antagonists were prepared with improved affinity compared with what was previously described. The results of a binding assay for the human TR and reporter cell assay revealed, within this series, that an m-bromobenzoyl substituent (11f) was optimal in terms of affinity and antagonist activity. Compared with already reported TR antagonists, their affinities are within the same range, thus potentially representing useful approach to novel and high-affinity TR-antagonists. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.01.009
点击查看最新优质反应信息

文献信息

  • Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
    申请人:Malm Johan
    公开号:US20050267206A1
    公开(公告)日:2005-12-01
    This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyrodism.
    这项发明涉及一种新型化合物,这些化合物是甲状腺受体配体,最好是拮抗剂,并且涉及使用这些化合物治疗心律失常、甲状腺功能亢进和亚临床甲状腺功能亢进的方法。
  • Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity
    作者:Johan Malm、Sandra Gordon、Peter Brandt、Bo Carlsson、Peter Agback、Anna Bäckbro Saeidi、Johnny Sandberg
    DOI:10.1016/j.bmcl.2007.01.009
    日期:2007.4
    Based on the concept of 'indirect antagonism' of nuclear receptors, a series of thyroid hormone receptor (TR) antagonists were prepared with improved affinity compared with what was previously described. The results of a binding assay for the human TR and reporter cell assay revealed, within this series, that an m-bromobenzoyl substituent (11f) was optimal in terms of affinity and antagonist activity. Compared with already reported TR antagonists, their affinities are within the same range, thus potentially representing useful approach to novel and high-affinity TR-antagonists. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多